Results of cleaved caspase-3 assay
. | Humanized mAbs, % relative to no mAb control . | . | . | Murine mAbs, % relative to no mAb control . | . | |||
---|---|---|---|---|---|---|---|---|
. | hL243γ4P . | hA20 . | hMN-14 . | mL243 . | mMN-14 . | |||
No cross-linking | ||||||||
Ramos | 26.9 | 3.2 | 0.8 | 15.8 | 3.9 | |||
Namalwa | 18.4 | –0.1 | 0.2 | 9.4 | 0.5 | |||
FSCCL | 46.4 | 0.7 | 0.3 | 26.2 | –0.7 | |||
Daudi | 48.1 | 7.9 | 0.9 | 45.8 | 1.0 | |||
RL | 22.5 | 1.5 | –0.1 | 18.2 | –0.3 | |||
SU-DHL-6 | 52.2 | 30.9 | 2.3 | 46.5 | 0.2 | |||
Raji | 22.5 | 1.5 | –0.1 | 18.2 | –0.3 | |||
With second antibody | ||||||||
Ramos | 71.7 | 67.8 | 7.3 | 40.3 | 3.0 | |||
Namalwa | 72.2 | 20.4 | 7.9 | 25.2 | –0.3 | |||
FSCCL | 86.7 | 20.0 | 8.4 | 55.0 | 1.5 | |||
Daudi | 68.9 | 72.0 | 2.9 | 51.2 | 0.0 | |||
RL | 37.3 | 24.2 | 4.0 | 4.0 | 0.7 | |||
SU-DHL-6 | 72.1 | 75.8 | 5.5 | 51.4 | –0.9 | |||
Raji | 59.8 | 37.4 | 2.8 | 20.4 | –0.3 |
. | Humanized mAbs, % relative to no mAb control . | . | . | Murine mAbs, % relative to no mAb control . | . | |||
---|---|---|---|---|---|---|---|---|
. | hL243γ4P . | hA20 . | hMN-14 . | mL243 . | mMN-14 . | |||
No cross-linking | ||||||||
Ramos | 26.9 | 3.2 | 0.8 | 15.8 | 3.9 | |||
Namalwa | 18.4 | –0.1 | 0.2 | 9.4 | 0.5 | |||
FSCCL | 46.4 | 0.7 | 0.3 | 26.2 | –0.7 | |||
Daudi | 48.1 | 7.9 | 0.9 | 45.8 | 1.0 | |||
RL | 22.5 | 1.5 | –0.1 | 18.2 | –0.3 | |||
SU-DHL-6 | 52.2 | 30.9 | 2.3 | 46.5 | 0.2 | |||
Raji | 22.5 | 1.5 | –0.1 | 18.2 | –0.3 | |||
With second antibody | ||||||||
Ramos | 71.7 | 67.8 | 7.3 | 40.3 | 3.0 | |||
Namalwa | 72.2 | 20.4 | 7.9 | 25.2 | –0.3 | |||
FSCCL | 86.7 | 20.0 | 8.4 | 55.0 | 1.5 | |||
Daudi | 68.9 | 72.0 | 2.9 | 51.2 | 0.0 | |||
RL | 37.3 | 24.2 | 4.0 | 4.0 | 0.7 | |||
SU-DHL-6 | 72.1 | 75.8 | 5.5 | 51.4 | –0.9 | |||
Raji | 59.8 | 37.4 | 2.8 | 20.4 | –0.3 |